JFSW THREE LIMITED

Company number 13671937 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

JFSW THREE LIMITED - Analysis Report

Company Number: 13671937

Analysis Date: 2025-07-29 13:44 UTC

Financial Health Assessment for JFSW THREE LIMITED as of 31 October 2024


1. Financial Health Score: C

Explanation:
JFSW THREE LIMITED exhibits signs of recovery from financial distress but remains in a borderline condition. The company has made significant improvements in working capital and current asset management, showing a "healthy cash flow" symptom through a large increase in net current assets. However, the overall net liabilities position and negative shareholders' funds indicate underlying "symptoms of distress" that require careful monitoring and corrective action.


2. Key Vital Signs

Metric 31 Oct 2024 31 Oct 2023 Interpretation
Current Assets £1,453,299 £29,231 Sharp increase mainly due to stock growth (£1.45m), indicating inventory build-up or property development activity.
Cash at Bank £8 £598 Critically low cash balance, a "weak pulse" warning for immediate liquidity needs.
Debtors £2,041 £4,779 Low debtor levels, suggesting tight credit control or limited receivables.
Current Liabilities £766,164 £29,393 Large rise, largely due to bank loans and trade creditors, indicating increased short-term obligations.
Net Current Assets (Working Capital) £687,135 -£162 Strong positive turnaround; a "healthy sign" showing current assets comfortably cover short-term debts.
Creditors (due after 1 year) £700,107 £0 Introduction of significant long-term debt, increasing financial leverage.
Net Assets -£10,488 -£112 Still negative, showing the company’s liabilities exceed its assets; a "chronic condition" needing attention.
Shareholders’ Funds -£10,588 -£212 Negative equity indicates accumulated losses or funding structure issues.

3. Diagnosis

JFSW THREE LIMITED is a property development company with a financial profile reflecting a transition phase. The company has significantly increased its stock (inventory of properties under development), which has boosted current assets and improved net current assets substantially. This suggests active investment in property projects.

However, the extremely low cash balance (£8) is a critical "symptom of distress," signaling potential liquidity crunch despite sizeable inventories. The company has also taken on substantial bank loans (£700k long-term) and increased short-term creditors, raising financial risk through leverage.

The negative net asset and shareholders’ funds position reveal accumulated losses or insufficient equity injection. This "underlying illness" points to either a start-up phase absorbing capital or operational losses that need to be reversed for sustainable health.

The absence of employees and a small debtor base might indicate a lean operation focused on project development rather than trading.

Overall, the company is in a fragile but improving state: it has "healthy working capital" but "strained liquidity" and "negative equity," requiring proactive financial management.


4. Recommendations

  • Improve Liquidity Management:
    Immediate focus on increasing available cash or liquid assets to avoid a cash flow crisis. Consider negotiating payment terms with creditors or securing short-term financing lines as a "supportive intervention."

  • Monitor and Manage Inventory Levels:
    The large stock holding should be carefully managed to avoid overstocking or obsolescence. Accelerate property sales or development completions to convert stock into cash flow.

  • Strengthen Capital Structure:
    Explore opportunities for equity injection or debt restructuring to improve net asset position and reduce financial risk. This is akin to "strengthening the immune system" to withstand future shocks.

  • Maintain Tight Credit Control:
    Keep debtor levels low and ensure prompt collection to support cash flow.

  • Regular Financial Health Monitoring:
    Frequent reviews of cash flow forecasts and balance sheet health to detect early warning signs of distress.

  • Strategic Business Focus:
    Confirm that property development projects are viable and aligned with market conditions to avoid asset impairment.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.